Pale Fire Capital SE’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
Other funds holding LRMR
Pale Fire Capital SE's LRMR Position: Q3 2026 in Review
Pale Fire Capital SE sold out of Larimar Therapeutics (LRMR) in Q3 2026, closing a stake of 43,000 shares — an estimated $131K sold.
Pale Fire Capital SE first reported a position in LRMR in Q3 2023 and held it in 10 quarters. The position peaked at $212K in Q3 2024. 145 funds tracked by Wall St. Rank hold LRMR as of Q3 2026.
- Pale Fire Capital SE reported no remaining Larimar Therapeutics position as of Q3 2026 after selling out during the quarter.
- Pale Fire Capital SE sold 43,000 Larimar Therapeutics shares in Q3 2026, an estimated $131K.
- Pale Fire Capital SE first reported a position in Larimar Therapeutics in Q3 2023 and held it in 10 quarters.
- Pale Fire Capital SE's Larimar Therapeutics position peaked at $212K in Q3 2024.
- 145 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q3 2026.
Based on Pale Fire Capital SE's 13F filing for Q3 2026, filed 13 Nov 2026.